How Healthcare M&A Firms Package Add-Backs Without Damaging Credibility

Key Takeaways

1. Credibility comes from proof, not “adjusted” storytelling.
2. The best add-backs are non-recurring, documented, and eliminable.
3. Buyers cut add-backs that look normal + recurring.
4. Sell-side QoE framing reduces retrade leverage and speeds diligence.
5. Over-adjusting can create leverage misses and buyer distrust.
   

Why Add-Back Packaging Can Make or Break Deal Credibility

In healthcare deals, buyers don’t hate add-backs—they hate unverified add-backs. The goal is a clean bridge from “books EBITDA” to “buyer-ready EBITDA” that can survive Quality of Earnings. Use an evidence-first mindset like QoE readiness and avoid surprises that stall momentum. >Diligence response discipline matters as much as the math.

The Credibility Rules You Can’t Ignore

A simple filter keeps you honest: if an expense is normal, recurring, and necessary to operate, excluding it can be misleading. That’s why serious advisors document logic, timing, and removability—rather than “labeling” costs as one-time. When packaging add-backs, align the narrative with how buyers test sustainability in premium deal packaging.

The Add-Back Evidence Pack Buyers Actually Trust

Treat add-backs like a mini audit: invoice → GL detail → payment proof → explanation → owner/controller sign-off. This mirrors how buyers pressure-test “adjusted EBITDA” in the market—because aggressive add-backs can contribute to projection misses and skepticism, as highlighted in S&P Global Ratings’ latest addback study (EBITDA addback research).

The Add-Back Categories Buyers Usually Accept

Owner comp normalization, one-time professional fees, and clearly non-recurring facility/IT events can be credible—if you trace each line to the GL and prove it won’t repeat. Use an evidence-first approach like this add-backs guide.

Owner Compensation Normalization

Buyers accept normalization when you benchmark role, hours, and market pay—then document it. Pair your schedule with a QoE lens from what buyers test in QoE, so adjustments don’t look like wishful math.

Staffing Disruption and Temporary Labor

Recruiter fees, locums, or overtime spikes can qualify when they’re tied to a clearly dated disruption and a documented resolution plan. If they look “ongoing,” buyers hesitate—often before LOI momentum—because recurring labor pressure reads as a durability risk rather than a one-time anomaly, which is why sell-side diligence teams emphasize separating true one-offs from repeatable operating costs (>Adjusted EBITDA: the seller vs. buyer tug of war).

Add-Backs That Get Cut in QoE

The first cuts are “normal and recurring” operating costs re-labeled as one-time, especially marketing, routine maintenance, and chronic billing leakage. SEC guidance flags excluding normal, recurring cash expenses in misleading ways. Keep answers tight and factual, like this response playbook.

Build the Monthly EBITDA Bridge (Books → Adjusted)

Create a monthly bridge that ties to the trial balance, with proof for every line. Good CIM packaging anticipates this format; QoE-ready packaging reduces pricing fog.

Quick Formatting Rule

Use a two-column schedule: “expense” and “why non-recurring,” with a date range. If it needs a long explanation, it’s probably not an add-back.

Stress-Test Add-Backs Like a Buyer

Run four tests: recurrence, cash, control, and evidence. Markets punish aggressive add-backs because they drive projection and leverage misses. Reinforce trust with clean cash mechanics like A/R and working capital.

Present Add-Backs Without Looking Defensive

The fastest way to lose trust is over-explaining. Instead, present a clean schedule, attach evidence, and answer diligence questions with calm specificity—using simple language: what happened, when it happened, why it won’t recur, and where the proof lives. That tone prevents retrade leverage and keeps the story intact, and it aligns with how credibility is assessed when companies present adjustments that could be viewed as potentially misleading if they remove normal operating costs (Deloitte DART guidance on potentially misleading non-GAAP measures).

Use Sell-Side QoE to Lock Credibility Early

Sell-side QoE creates shared definitions between seller and buyer. It separates management’s “adjustments” from what’s actually defensible, which reduces back-and-forth and speeds confirmatory diligence. ACG’s middle-market research connects QoE usage with stronger outcomes in transactions, reinforcing the value of doing this work upfront. Build that readiness into your process using this QoE preparation guide.

What to Disclose Early vs. Later

Disclose high-confidence add-backs early (clean documents, easy verification). Hold back borderline items until you’ve stress-tested them—because once a buyer flags one weak add-back, they scrutinize everything.

Common Mistakes That Destroy Trust

Mixing personal expenses with operational items, changing definitions mid-process, or failing to reconcile to the GL creates a credibility gap. Buyers interpret that gap as risk and price it into structure—earnouts, holdbacks, and tighter reps. Don’t let packaging mistakes weaken competitive tension; a multiple-offer strategy works best when the numbers are clean.

A Practical “Credible Add-Back” Checklist

A credible add-back has (1) a non-recurring event, (2) documented proof, (3) clear removability, (4) a consistent definition, and (5) a GL tie-out. Standardize the package so every buyer sees the same story—because inconsistent or overly aggressive adjustments can inflate projections and ultimately lead to underwriting and leverage misses in real transactions (S&P Global Ratings EBITDA addback study).

Conclusion

Credible add-backs aren’t about “bigger EBITDA”—they’re about defensible adjustments with a clean GL tie-out and proof that the cost truly won’t recur. Standardizing definitions and documentation across every adjustment keeps buyers focused on earnings durability instead of skepticism. When your add-back story is consistent, evidence-backed, and easy to validate, you reduce retrade leverage and protect deal terms.

FAQs

1) How many add-backs is too many?
When they become the story instead of supporting it—buyers start cutting.

2) Can I add back marketing spend?
Only if it’s truly non-recurring and evidenced; otherwise it’s “normal and recurring.”

3) Do buyers accept staffing disruption costs?
Often yes, if dated, documented, and clearly resolved.

4) What’s the difference between add-backs and pro forma?
Add-backs remove non-recurring items; pro forma assumes future operational changes.

5) Should I do sell-side QoE?
If you want speed and fewer retrades, it’s usually worth it.